Addie: Feline infectious peritonitis treatment
www.catvirus.com
1
Feline infectious peritonitis (FIP) treatment
Diane D. Addie PhD, BVMS, MRCVS
www.catvirus.com
22 Feb 2018
IMPORTANT NOTICE
Prior to even considering treatment for feline infectious peritonitis (FIP) you
absolutely MUST ensure that the cat really does have FIP. At time of writing, FIP
treatment is mainly immunosuppressive and immunosuppression of a cat with an
infection other than FIP will kill the cat.
Do a FCoV antibody test: provided the test is sensitive enough, a negative result will rule out
FIP. Addie et al, 2015
You can find out which FCoV antibody tests are recommended (and which
ones are useless) at www.catvirus.com/FCoVantibody.htm.
A major differential of FIP is toxoplasmosis: run a toxoplasma antibody test in at-risk cats, for
example those with access to outdoors or who are fed butcher meat. However a positive FCoV
antibody test does NOT confirm FIP.
PREVENTION IS BETTER THAN CURE It is my hope that by the time you have listened to this webinar you will have understood the complexity
of the disease that is FIP. In many other diseases, the destruction of the invading pathogen, by antivirals
or antibiotics, results in the cure of the patient, but FIP is a disease involving the very complex immune
response of the cat. If we don’t completely understand the pathogenesis of FIP how can we hope to fix
it? And the disease isn’t a fixed target, it changes, the pathology changes throughout the infection. FIP
is slightly different in every individual so treatment needs to be tailored to that individual patient: it is
not a case of one size fits all. Therefore it is my view that prevention of FCoV infection is preferable to
an attempt to cure, and prevention can be achieved by hygiene and education.
Addie: Feline infectious peritonitis treatment
www.catvirus.com
2
PATHOGENESIS OF FIP Due to the slowness of my internet connection I am unable to incorporate some of my important videos into the lecture: please do watch them – they can be counted as CPD.
Please watch my animation of FCoV transmission on
http://www.youtube.com/watch?v=rkqUjeQNEQs
Please watch my animation of FIP pathogenesis on http://www.youtube.com/watch?v=6RyI2LI9R9Q&feature=related
In brief, feline infectious peritonitis (FIP) is the result of an excessive inflammatory response to
infection with feline coronavirus (FCoV). FCoV transmission is indirect, from contact with virus in
faeces, usually from a shared litter tray or via fomites on a litter scoop, brush, floor, etc. The virus is
ingested, is believed to replicate first in the epithelial cells of the small intestine, it undergoes a brief
viraemia, Porter et al, 2014
then is shed from the ileum and colon Herrewegh et al, 1997
into the faeces. In around
90% of cats, virus shedding lasts for a few months in type I FCoV infection, Addie & Jarrett, 2001
and
approximately 2 weeks in type II FCoV infection. Stoddart et al, 1988
In a minority of cats the virus is able to
hijack the monocyte and replicate within it. Regardless of the pathogenicity of the coronavirus infecting
it, the monocyte controls the amount of viral replication within it. Dewerchin et al, 2005
The key cell in the pathogenesis of FIP is the monocyte / macrophage. FCoV-infected
monocytes/macrophages release matrix metalloproteinase (MMP) 9; Kipar et al, 2005
tumour necrosis factor
(TNF)-α; Kipar et al, 2005;
Takano et al, 2007a & 2009
interleukin (IL) -1β and IL-6,Goitsuka et al, 1990
. MMP-9 allows
the extravasation of FCoV-infected monocytes. TNF-α is a major contributor to the inflammatory
response and pathogenesis of FIP. TNF-α is very likely the cause of the lymphopenia seen in FIP. Takano
et al, 2007b TNF-α upregulates fAPN (the receptor for type II FCoVs)
Takano et al, 2007a and, along with GM-
CSF and G-CSF which are also produced by FCoV-infected monocytes, is a neutrophil survival factor. Takano et al, 2009
In later infection, TNF-α production shifts from macrophages to lymphocytes. Dean et al, 2003
Chronic over-production of TNF-α results in cachexia.
In early infection, IL-6 stimulates hepatocytes to release acute phase proteins (such as alpha-1 acid
glycoprotein, AGP). Hepcidin is a type 2 acute-phase protein and iron regulatory hormone which
inhibits iron export from the gut and macrophages by binding to ferroportin: hepcidin is produced
mainly by the liver in response to IL-6. IL-6 causes B lymphocytes to proliferate and differentiate into
plasma cells. Takano et al, 2007b
It is likely that high IL-6 levels found in cats with FIP are the cause of
hypergammaglobulinemia. IL-6 can be pro-inflammatory or anti-inflammatory.
Addie: Feline infectious peritonitis treatment
www.catvirus.com
3
From this brief synopsis, it is apparent that FIP treatments fall into one or more categories:
Treatment strategy Examples
Anti-virals GC376
Feline interferon omega (Virbagen Omega, Virbac)
Human interferon
Cyclosporin A
Support the monocyte /
immune system
Arginine: i.e. real meat daily
Feline interferon omega (Virbagen Omega, Virbac)
Polyprenyl Immunostimulant (Sass and Sass)
Anti-inflammatories and
immunosuppression
Corticosteroids e.g. prednisolone
Meloxicam (Metacam, Boehringer Ingelheim)
Cyclosporin A
Thalidomide
Targeted modification of the
immune response Anti-TNF-α (metronidazole); anti-TNF- α antibodies (e.g.Infliximab)
? Anti-IL-6 antibodies (e.g. Siltuximab)
? Curcuma longa (turmeric)
? anti-MMP-9 (e.g. doxycycline)
Counteract FIP anaemia Erythropoietin
Erythropoietin was added to this list because non-regenerative anaemia is a consequence of FIP: see
notes on anaemia below.
FIRST STEP TO TREAT EFFUSIVE FIP: DRAW OFF THE EFFUSION! Abdomino- or thoraco-centesis will also physically remove virus-infected cells which are a source of
pro-inflammatory cytokines. Drawing off the effusion will immediately make the cat more comfortable,
especially in thoracic effusive FIP where the cat will be able to breathe better. Remember that the cat
has an intact mediastinum, so you will need to draw effusion off from both sides of the thorax. While
you have the needle in place you can administer feline interferon omega directly to the site of the virus
infection. Effusion can often be removed with minimal restraint and without sedation: in fractious cats,
clipnosis can be attempted: put bull clips or clothes pegs onto the scruff of the neck – the cat will often
go limp for some minutes. Pozza et al, 2008
The effusion should be sent for FCoV RT-PCR to confirm the diagnosis of FIP.
TREATMENT PROTOCOLS AND DOSES OF COMMONLY AVAILABLE DRUGS Remember to get clients to sign an informed consent form when using drugs off-label.
Addie: Feline infectious peritonitis treatment
www.catvirus.com
4
ANTI-VIRALS
INTERFERONS
Interferons work best administered as closely as possible to the site of infection.
Recombinant feline interferon omega (Virbagen Omega,® Virbac, France)
Feline interferon omega is an alpha interferon and can resist stomach acid. Once a vial is reconstituted, it
will keep for up to 3 weeks at 4oC, or up to 6 months in a freezer.
Dose for effusive FIP: 1 MU*1/kg every other day, and then twice a week for however long it takes
until recovery is obtained or until death administered initially into the abdominal or thoracic cavity (i.e.
the site of the effusion) or subcutaneously.
Dose for non-effusive FIP: 100,000 Units of feline interferon omega per day per os
Diluting Virbagen Omega Virbagen Omega (VO) comes in vials of 10 million units. It should be reconstituted with 1ml of diluent.
Using 10 x 1ml insulin syringes withdraw 0.1ml into each of ten 1ml syringes: you now have 1 MU of
VO per syringe. Freeze 9 of the syringes in a baggie (they will last up to 6 months in the freezer).
Put 1 syringe content (0.1ml) of reconstituted VO IFN (which now has 1 million units of VO) into 4.9
mls of saline or water: this gives you 100,000 units per half ml. Give the cat 0.5 mls of the mixture
daily on food, or gently squirted into the side of the mouth at the commissure of the lips, with the head
gently tilted backwards to encourage swallowing. This diluted mixture will last up to 21 days at 4oC.
Human interferon alpha Interferons are species specific which is why it’s better to use feline interferon than human interferon.
However, the human one is all that’s available in some countries.
Dose: Non-effusive feline infectious peritonitis (FIP): 30 i.u./daily or for 7 days at alternate weeks given
by mouth.
In effusive FIP 30 i.u./daily can be used, or larger doses of interferon can be given by intramuscular
injection daily (104 –106 i.u. per day). By 6–7 weeks, if the cat is still alive, interferon will no longer
work at this dose because the cat will make antibodies against it.
To obtain human interferon-alpha write a prescription for your local pharmacist. Obviously, in areas
where feline interferon is available it is preferable as it is likely to have more effect than the human
interferon.
GC376
Some cat guardians want to go beyond what is currently available and seek the newest possible
treatments. At present, this usually manifests as a request for treatment of their pet with GC 376: at time
* MU = Million units
Addie: Feline infectious peritonitis treatment
www.catvirus.com
5
of writing (February 2018) there are no clinical trials of this drug ongoing. Updates on its progress are
available on www.sockfip.org.
SUPPORT THE MONOCYTE / MACROPHAGE AND THE IMMUNE SYSTEM
FEED REAL MEAT TO GIVE THE CAT ARGININE
Key message: do NOT give L-lysine to a cat with FIP
Arginine is an essential amino acid in the cat: Morris and Rogers, 1978
necessary for effective function of both
the urea cycle and the monocyte / macrophage. Give real meat daily to augment arginine levels: even
just a tablespoonful a day will make a difference. Or regularly use commercially available real meat
based cat foods such as Applaws & Almo Nature (available from the Zooplus website in Europe: use
Zooplus link on the catvirus website links page to obtain a discount).
POLYPRENYL IMMUNOSTIMULANT – FOR TREATING NON-EFFUSIVE FIP ONLY
There has been no placebo-controlled clinical trial of PPI in cats with FIP published, and a major
problem with the recent publication by Prof. Legendre was that FIP was not diagnosed beyond
reasonable doubt in the 60 cases described. Legendre et al, 2017
I am keen to amass independent data on FIP
treatment using PPI and would love to hear from veterinary surgeons using it: my email address is
PPI is a treatment for non-effusive FIP; it is not recommended in effusive (wet) FIP. PPI is used off-
label in FIP treatment.
Survival was better in cats not concurrently treated with systemic corticosteroids, but it is probably safe
to use topical ophthalmic corticosteroid treatment along with PPI in cats with intra-ocular signs of non-
effusive FIP. Legendre et al, 2017
UK veterinary surgeons will need to apply to the VMD for special import permission.
To obtain PPI: email [email protected], or visit www.vetimmune.com.
Dose: 3.0 mg/kg orally of Polyprenyl Immunostimulant three times a week.
ANTI-INFLAMMATORIES AND IMMUNOSUPPRESSION Cats receiving immunosuppressants should also receive antibiotic cover to protect them against
secondary infections (see section below on Antibiotics). Do a toxoplasma antibody test to determine
whether there is a risk of activating toxoplasmosis by immunosuppressing the cat: if so, use clindamycin
for 4 weeks. Warn the cat’s guardian that latent FHV could also recrudesce.
CORTICOSTEROIDS given to both effusive and non-effusive* FIP cases
*unless the cat is being treated with Polyprenyl Immunostimulant (PPI). Systemic corticosteroids are contraindicated in non-effusive FIP cases being treated with PPI, although topical corticosteroids can be used in ophthalmic preparations. Legendre et al, 2017
Addie: Feline infectious peritonitis treatment
www.catvirus.com
6
Prednisolone Prednisolone is the main anti-inflammatory / immunosuppressant used in feline infectious peritonitis
therapy, though unfortunately it suppresses both the humoral and cell-mediated immune response. It is
possible that we should be using an anti-inflammatory, rather than an immunosuppressive dose,
especially in effusive FIP, whereas in non-effusive FIP the immunosuppressive dose makes more sense.
2 mg/kg/sid is the high end of an anti-inflammatory dose and low end of immunosuppressive dose.
Trepanier, 2015
Prednisolone should never be used in cats with toxoplasmosis, or septic peritonitis or pleurisy, which is
one reason why cytology of the effusion is a very important part of FIP diagnosis, as there will be many
more white blood cells in the effusion of a cat with sepsis, and a good cytologist will detect the bacteria
or fungi. If in doubt, send the effusion for bacterial culture.
Dose: 1-2 mg/kg/ sid given by mouth, halving the dose every 10-14 days, right down to 0.5 mg/kg every
other day or until an optimal dose for that cat is found (this will be the dose at which alpha-1 acid
glycoprotein (AGP) levels have reduced to, and remain at, normal. (See the section below on monitoring
treatment.)
Prednisone is not recommended in cats: it is not as effective as prednisolone. Trepanier, 2015
Dexamethasone / injectable corticosteroids Dexamethasone (or other injectable corticosteroids) can be used to kick start the immunosuppressive
treatment (or for cats which cannot be pilled). It can also be administered directly to the site of
inflammation in effusive FIP cases.
Dose: dexamethasone 1 mg/kg intrathoracic or intraperitoneal injection on one occasion or every 5 days.
MELOXICAM (METACAM, BOEHRINGER INGELHEIM)
Provided kidney function and blood pressure are normal, consider using the non-steroidal anti-
inflammatory meloxicam instead of corticosteroids. Meloxicam was used for 119 days, along with one
month of metronidazole, in one FIP case report in a cat who survived 787 days. Hugo and Reading, 2015
Dose: 0.05 mg/kg BW, PO, q24h
CYCLOSPORIN A
Has anti-FCoV and immunosuppressant activity.
Use only in cats with toxoplasma antibody titres of zero or give concurrent clindamycin treatment.
Warning: if you give CsA to a FCoV-infected healthy, or diarrhoea-only, cat, you WILL induce
FIP. Only use with extreme caution.
Dose: start at 75 mg/cat/day
reduce to 50 mg/cat/day
reduce to 25 mg/cat/day
THALIDOMIDE
Addie: Feline infectious peritonitis treatment
www.catvirus.com
7
The rationale of using thalidomide instead of corticosteroids in the treatment of feline infectious
peritonitis is to reduce inflammation and the humoral immune response to feline coronavirus while
leaving the cell mediated (anti-viral) immune response intact. Thalidomide is actually a very safe drug.
Be sure to obtain the owner's consent for using a drug not licensed for cats.
Dose: 50-100mg at night. DO NOT USE IN PREGNANT CATS as it is teratogenic.
ANTIBIOTICS Antibiotic cover is essential when immunosuppressing a cat, with either high dose corticosteroids,
cyclosporin A or anti-TNF-alpha antibodies. Your choice of antibiotics will largely depend on what
your major differential diagnoses are, given the presenting clinical signs. For example, if you are
awaiting FIP confirmation from your laboratory and your major differential diagnoses are
toxoplasmosis, or bacterial peritonitis / pleurisy, then clindamycin (Antirobe) will be your antibiotic of
choice because it covers both aerobic and anaerobic infections; if your major differential is infectious
anaemia, then doxycycline or oxytetracycline will be your choice. Sub-antimicrobial doses of
tetracyclines have anti-MMP activity, which means that they might be a good choice in early effusive
FIP treatment. However, doxycycline should not be used in healthy FCoV carrier cats, at least until
further information becomes available, because doxycycline inhibits interferon-beta and was shown to
increase shedding of the pig coronavirus, transmissible gastroenteritis virus, in vitro. Xing et al, 2017
The most commonly used antibiotic in cats in the UK is cefovecin (Convenia, Pfizer) because of
difficulty in administering pills to cats. Singleton et al, 2017
Cefovecin may be a good choice but I have not
found any publications on its effect on the immune system, although there is a record of it having been
used, along with many other drugs, in FIP in one case report. Hugo and Reading, 2015
It has the advantages of
being administered by a veterinary surgeon, so there is no problem with owner compliance/ability to
dose the cat, and there is no risk to the oesophagus.
A few studies reported that amoxicillin/clavulanic acid (Synulox) can decrease IFN gamma, which is
essential for FIP survival, although those studies were based on laboratory experiments. Brooks et al, 2003;
Padovan et al, 1999 A study in healthy human volunteers showed no interference with IFN gamma.
Dufour et al,
2005
Metronidazole is effective against anaerobic organisms, so is a good choice where bacterial pleurisy is a
differential diagnosis. It inhibits TNF-alpha—i.e. is anti-inflammatory—and was used for one month,
along with meloxicam, in one FIP case who survived 787 days. Hugo and Reading, 2015
However, it is
horrible to taste and can be difficult to administer to cats.
Where antibiotics are used, probiotics should also be given to replenish the microbiome and avoid
overgrowth by pathogenic gut bacteria: my choice is Swanson's Lactococcus rhamnosus - one capsule
per day mixed into food or drink. We have cultured capsules of these in our laboratory at Glasgow and
verified that they contain what is claimed. The Protexin from Australia is also very good but
unfortunately not very palatable:
www.pets-megastore.com.au/protexinprobioticpowder250gms-p-1733.html
Addie: Feline infectious peritonitis treatment
www.catvirus.com
8
ERYTHROPOIETIN When a cat with FIP has a decreasing rbc count with no evidence of regeneration, then use
erythropoietin, preferably while the Hct is still in the twenties: when it gets lower than 20, it may be too
late.
Dose: A 0.2 ml darbepoetin s.c. injection (0.5 micrograms/kg) given twice weekly to be gradually
reduced, depending on PCV.
This is based on Chalhoub's paper quoting a weekly dose of 1 microgram/kg/week. Chalhoub et al, 2012
FIP PROGNOSIS Cats with effusive FIP usually die more quickly than those with non-effusive FIP: the median survival
time for 33 cats with effusive FIP was 21 days (± 20 days) in one study, Tsai et al, 2011
and 9 days in another
study of 36 cats. Ritz et al, 2007
The cats in the latter study were subjected to biopsy and the additional stress
may have adversely affected their survival time. Ritz et al, 2007
They also received amoxycillin/clavulanic
acid which was reported to decrease interferon-gamma: a key cytokine in FCoV/FIP survival. In
addition the authors of that study surmised that their failure to taper the immunosuppressive doses of
corticosteroids predisposed to secondary infections which led to the deaths of 5 cats. Ritz et al, 2007
Concurrent systemic corticosteroid administration was also noticed to decrease the survival of cats in a
PPI study. Legendre et al, 2017
Cats with thoracic effusion seem to fare better than cats with an abdominal effusion. Cats treated with
Virbagen Omega have been documented as surviving 18 months or more. Ishida et al, 2004; Gunn-Moore & McCann,
2004
In a recent therapeutic study of 60 cats with a presumptive diagnosis of non-effusive FIP, 20%
survived over 200 days: survival varied with sub-type of disease, the most severe being neurological
signs, where mean survival was 38.8 days. Legendre et al, 2017
The manifestation of non-effusive FIP with
the best prognosis appears to be mesenteric lymph node adenopathy as the key clinical finding.
Staging for effusive FIP prognosis to help you to assess whether treatment has a chance of helping or not In this staging system shown in the table below the severity of effusive FIP can be worked out, which
will give you an idea of whether or not it is worth obtaining special drugs to treat, or whether it is
worthwhile continuing treating a case. Look at the parameter in the left hand column, then look at
where the result of your case falls in the range, then put the score for that parameter into the next free
column in the grey shaded cells. Finally work out the total score for your case. An excel file of this table
can be downloaded at http://www.catvirus.com/downloads.html: the total score will automatically fill in
the cell at the bottom. A video of using this table can be found at https://youtu.be/F6FXcWgEZxU.
Interpreting the total score for your case:
0-4: survival time more than 2 weeks
Addie: Feline infectious peritonitis treatment
www.catvirus.com
9
5-11: survival time less than 2 weeks
over 12: survival time less than 3 days
While this isn’t an absolutely exact predictor, it does give a ballpark indicator of prognosis.
Remember that even giving the cat a few more days can help the cat’s guardian come to terms with the
imminent demise of their pet: corticosteroids don’t cost much and will help ease those last days. Draw
off the effusion to make the pet more comfortable. FIP doesn’t seem to be a painful condition.
Parameter Range Score Your
case date
Your
case date
Your
case date
PCV
(%)
>26
20 – 26
<20
0
2
4
AST
(U/L)
<150
150 – 300
>300
0
2
4
Total bilirubin
(mg/dl)
[umol/L]
(< 0.5) [<8.5]
(0.6 – 2.2) [ 9 – 38 ]
(> 2.2) [ >38 ]
0
2
4
Potassium
(mmol/L)
4.0 – 5.8
3.0 – 3.9
< 3.0
0
2
4
Sodium
(mmol/L)
156 – 165
150 – 155
<150
0
2
4
Total
This table is adapted from that of Tsai et al, 2011. It can be downloaded from the catvirus.com Downloads page and I hope to have a video of using it in the FIP treatment page of the website and it can be seen here:
https://youtu.be/F6FXcWgEZxU.
FIP AND ANAEMIA For FIP treatment to be effective, the causes of the anaemia associated with FIP need to be elucidated
and treated. Commonly two types of anaemia are observed in FIP cases: non-regenerative anaemia,
assumed to be that of chronic disease, and acute haemolytic anaemia: the latter causing the death of
many cats with FIP. Riemer et al 2016
documented anaemia (defined as a packed cell volume less than
30%) in 106 of 200 cats with FIP, with 21 having a Hct of 20% or less. Tanaka et al 2015
cited anaemia
Addie: Feline infectious peritonitis treatment
www.catvirus.com
10
as the cause of death in 2 of 3 cats treated with Cyclosporin A. Tsai et al 2011
noted that a fall in Hct
heralded the imminent demise of the patient. Anaemia has been reported as a side effect of interferon
treatment in humans, but Tsai et al 2011
found that anaemia occurred equally in groups of cats treated and
not treated with interferon.
Non-regenerative anaemia of chronic inflammation I believe that FCoV/FIP could be one of the unrecognised and under-diagnosed causes of severe non-
regenerative anaemia and haemolytic anaemia in FeLV-negative cats. In a retrospective study of 180
cats with anaemia, FIP was diagnosed in only 17 Korman et al, 2013
but likely was not tested for in most cases
(S. Tasker, personal communication). The reason that the anaemia of FIP has not been given more than
a passing comment previously might be because feline red blood cells circulate for approximately 73
days, White & Reine, 2009
which is longer than most cats with effusive FIP survive. Few reported cases
survive beyond the two-month time-point and the reason for this could be that cats with FIP simply run
out of erythrocytes as a consequence of FIP-induced erythroid bone marrow suppression. The survival
of many cats with FIP might be increased if the bone marrow suppression could be reversed. Tanaka et
al 2015
described one case, treated with Cyclosporin A, where a single treatment with erythropoietin at
around day 60 post-diagnosis reversed the trend of declining Hct and the cat survived another 200 days,
by which time she was 15 years old.
In many cases of FIP there are many pyogranulomata in the kidney cortex, thus another mechanism
which may be involved in the anaemia of FIP could be lack of erythropoietin causing erythroid
hypoplasia/aplasia. Chalhoub et al 2012
treated a cat by kidney transplant and darbopoietin: the cat
survived another year, although it was unclear whether FIP was the cause of the kidney failure or if it
developed due to the immunosuppression following transplant.
The simple inability to synthesise red blood cells does not seem to fully explain FIP-associated anaemia.
White and Reine 2009
stated “Cats tend to develop anaemia of inflammatory disease within two to three
days of the onset of the inflammatory process, and the haematocrit drops by an average of 8%.” The
feline erythrocyte lasts around 73 days, so with non-regenerative anaemia one would expect Hct to fall
by approximately 10% in a week: if it falls more than that in a FIP case, check a blood smear for signs
of immune-mediated haemolytic anaemia: acanthocytes and schistocytes which suggest a degree of
mechanical trauma to red cells. Check for rising bilirubin levels although normal bilirubin levels have
been reported in cats with immune-mediated haemolytic anaemia. Swann et al, 2016
Macrophages are widely distributed in peripheral tissues where they play a crucial role in the defence
against pathogens. This is achieved, at least partially, through the control of intracellular iron
availability, which limits pathogen growth. Gan et al, 2017
Macrophages also play a key role in body iron
homeostasis by recovering iron from effete red blood cells and returning it to the circulation. Gan et al ,2017
M1 polarised macrophages, deal directly with microbes at sites of infection and are pro-inflammatory,
releasing high levels of tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). Retention of iron
in M1 macrophages reduces circulating iron levels and thus the availability of this essential nutrient for
extracellular microbes. This also limits the amount of iron available for erythropoiesis, a mechanism
involved in anaemia of inflammatory disease. Gene expression analysis of M1 macrophages showed a
high level of ferritin, associated with iron storage, and a low level of ferroportin, associated with iron
Addie: Feline infectious peritonitis treatment
www.catvirus.com
11
export. Compared to unstimulated macrophages, transcriptional changes were also noted in hepcidin and
transferrin receptors, both iron regulators which favour iron sequestration in the reticuloendothelial
system. Gan et al ,2017
In contrast to M1 cells, M2 polarised macrophages are anti-inflammatory and have
an iron-release phenotype mediated through an elevated expression of ferroportin. Kramyl, 2017
Microcytosis, which occurs in iron deficiency, was noted in 35% of 188 cats with FIP, of which many
were not yet anaemic. Riemer et al, 2016
Macrophages loaded with iron lose their ability to kill intracellular
pathogens such as Salmonella, Mycobacterium, Chlamydia, and Legionella by IFN- -mediated
pathways . Gan et al ,2017
Presumably, their ability to deal with intra-cellular coronaviruses is similarly
inhibited, thus sequestration of iron in macrophages is doubly hazardous for the cat with FIP, both
leading to anaemia and reducing the macrophage’s ability to destroy the virus.
Immune-mediated haemolytic anaemia The second type of anaemia seen in FIP, acute haemolytic anaemia, is less common but more acutely
fatal. Norris et al 2005
reported 2 of 42 cats with FIP dying of acute haemolytic anaemia and an acute
anaemic crisis leading to euthanasia 7 weeks post-diagnosis has been encountered previously in a FIP
case treated with adipose stem cell therapy (Andy Armitage, personal communication) and in a non-
effusive FIP cat within 4 weeks of onset of clinical signs. Three (2.8%) of 107 cats with immune-
mediated haemolytic anaemia (IMHA) had FIP, 35 of 107 cases had secondary IMHA Swann et al, 2016
and
3 of those cats had FIP, thus 8.6% of secondary IMHA was due to FIP (J. Swann, personal
communication). Tsai et al 2011
noted that all of 51 cats with FIP were moderately to severely anaemic
prior to death. Falling Hct, rising bilirubin and AST were found to be adverse prognostic signs, all being
parameters indicative of intravascular haemolysis. However, Riemer et al 2016
found that only 38 of 109
cats (35%) with hyperbilirubinaemia, but without raised liver enzymes, were anaemic. Raised bilirubin
occurred in 91 of 134 (68 %) of cats with effusion and 15/35 (43 %) of cats with non-effusive FIP. The
authors explained this phenomenon as indicative of increased erythrocyte fragility in FIP.
Erythrophagocytosis was seen in 17 of 28 FIP effusions. Felten et al, 2017
Haemolytic anaemia has been reported in other viral infections such as African Swine Fever, Karalyan et al,
2016 Epstein-Barr virus,
Ontanilla-Clavijo et al, 2017 Human Influenza virus,
Shizuma, 2014 and Parvovirus B19.
Iidaet al, 2016 In contrast, in cats haemolytic anaemia is most frequently associated with infection with
feline leukaemia virus or the haemotropic mycoplasma bacterium. Swann et al, 2016; Tasker et al, 2009
The
pathogenesis of immune-mediated haemolytic anaemia is difficult to explain, and may be different in
each infection. One possible explanation for the haemolytic anaemia of FIP might be that IL-6 causes
the activation of auto-reactive plasma cells. Ironically, bilirubin inhibits the expression of TNF-α
related endothelial adhesion molecules E-selectin and VCAM-1 Mazzone et al, 2009
which contribute to the
pathogenesis of FIP phlebitis by enabling monocyte attachment and extravasation. Acar et al, 2016
MONITORING TREATMENT AND THE CAT’S PROGRESS In my experience, the most efficient measure of a treatment working is when AGP level reduces,
especially if it reduces to normal levels (up to 500 μg/ml). Haematocrit (Hct) should be monitored
continuously to assess anaemia.
Addie: Feline infectious peritonitis treatment
www.catvirus.com
12
WHEN TO ANNOUNCE RECOVERY AND DISCONTINUE TREATMENT When a cat is eating well, regained normal weight and temperature, and AGP, globulin levels,
Hct and lymphocyte count have all returned to normal, the question will arise whether or not it is
safe to discontinue treatment. Cessation of virus shedding in faeces does not always indicate
that the virus has been eliminated from the entire body.
To be absolutely certain that the cat has recovered, as opposed to being in remission, the FCoV
antibody titre should have reduced to zero using a sensitive FCoV antibody test.
WHEN TO STOP TREATMENT AND EUTHANASE 1. If the cat develops neurological signs.
2. If the cat develops non-regenerative anaemia, haematocrit below 20%, with no response
to erythropoietin.
3. If the cat develops immune-mediated haemolytic anaemia: don’t try a transfusion, it is
unlikely to work.
TARGETED MODIFICATION OF THE IMMUNE RESPONSE: POSSIBLE FUTURE
THERAPIES If you do go down the route of using a drug off-label, make sure that your practice has a well-drafted
consent form which absolves you of any legal liability, and ensure that the client signs it. Take time to
explain any possible risks of side effects to your client.
CURCUMIN
Curcumin is the principal curcuminoid chemical of turmeric (Curcuma longa) rhizomes which are
increasingly available in organic, health food, and Asian shops. This chemical has been shown to
possess anti-inflammatory, Allijn et al, 2016
anti-viral von Rhein et al, 2016; Zhu et al, 2015
and antioxidant properties Leray et al, 2011
and is available as a herbal supplement. Compared with prednisolone, curcumin had
superior activity in suppressing two key pro-inflammatory cytokines implicated in FIP development,
TNF-α and IL-6. Allijn et al, 2016
Curcumin has previously been used in cats resulting in a reduction in the
level of the acute phase protein AGP. Leray, et al, 2016
Curcuma longa rhizomes are not associated with
some of the drawbacks of turmeric powder, which often contains unknown preservatives and fillers and
the cat is exquisitely sensitive to many chemicals. However, in one case of FIP treated with curcumin in
which we have monitored AGP, neither prednisolone nor curcumin were able to reverse the adverse
effects of IL-6, since AGP remained elevated throughout.
Dose: instruct the cat’s guardian to liquidise a 1cm long piece of fresh C. longa rhizome in omega-3 rich
oil every 3 days, store the mixture at 4oC and administer 0.5mL daily. Alternatively, use ¼ teaspoon of
ground organic turmeric, but be aware that turmeric powder is often mixed with other substances, which
may be toxic to cats.
Addie: Feline infectious peritonitis treatment
www.catvirus.com
13
ANTI-TNF-ALPHA ANTIBODIES (E.G. INFLIXIMAB)
Dr Ishida and I postulated the use of anti-TNF-α antibodies as a possible treatment for FIP in 2008.
Doki et al, 2016b
used anti-feline TNF-α antibodies synthesised in their own laboratory to prevent FIP
development in 2 of 3 cats experimentally infected with a strain of FCoV known for its virulence.
Infliximab is a monoclonal antibody that binds human TNF-α and is used to treat autoimmune diseases
in humans. As TNF-α is highly conserved at a protein level amongst mammalian species Soller et al, 2017
infliximab it is likely to also bind feline TNF-α. I have experience of using it in only one cat and
unfortunately he developed iritis and we lost him to immune-mediated haemolytic anaemia.
TNF-α is essential for an effective immune response against bacteria and suppressing it in a bacterial
peritonitis or pleurisy would be catastrophic.
Dose: one administration of 4mg/kg given in a 0.9% saline infusion over a four-hour period.
ANTI-IL-6 ANTIBODIES (SILTUXIMAB)
Antibody against IL-6 siltuximab (Sylvant) has not yet been tried in any FIP case. IL-6 can be pro-
inflammatory or anti-inflammatory so that the effect of inhibiting its action is not known. However, in a
cat who is going to die of immune-mediated haemolytic anaemia, it might be worth trying.
ADIPOSE STEM CELL THERAPY
We have attempted treatment of two cats with FIP with adipose stem cell therapy: unfortunately both
cats died. The UK expert on Adipose Stem Cell Therapy is Dr Andy Armitage of Greenside Veterinary
Practice. www.greensidevetpractice.co.uk.
PLASMAPHERESIS
Antibodies have a key role in the development of FIP so plasmapheresis to remove them might help cats
with FIP.
PREVENTION IS BETTER THAN CURE By now you will have realised the enormous complexity of unravelling the immune reaction which is at
the heart of the development of FIP. Furthermore, you would have to work out precisely what was
happening in each individual cat before you would know whether it is best to use antivirals, or to inhibit
MMP-9, or TNF-alpha, or IL-6. How could you shift M1 macrophages to M2 macrophages and would
you heal or kill the cat by doing so? How will you reverse the anaemia which the case likely has?
Preventing FIP is more feasible than curing it, and will be the subject of the next webinar in this series.
Addie: Feline infectious peritonitis treatment
www.catvirus.com
14
SURVIVAL OF CATS IN RECENT STUDIES WHICH TREATED NATURALLY OCCURRING FIP (AND
TWO EXPERIMENTAL INFECTIONS)
Definitions of survivors by authors
Survival Number of cats
FIP type Treatment Antivirals are in
blue, anti-
inflammatories are
underlined.
Reference
Remission 11.2 months post treatment
6 or 7 of 20
6 effusive 1 non-effusive
GC376: a 3C like protease inhibitor
Pedersen et al, 2017
Recovery up to 8 months 6 of 8 effusive (experimental infections)
GC376: a 3C like protease inhibitor
Kim et al
Remission > 2 years 4 of 12 effusive fIFN omega Ishida et al
Partial remission
2-5 months 4 of 12 effusive fIFN omega Ishida et al
Very short term
< 7 days 8 of 21 effusive fIFN omega and prednisolone
Ritz et al
Short term 7-21 days 10 of 21 effusive fIFN omega and prednisolone
Ritz et al
Medium term 21 days to 3 months
2 of 21 effusive fIFN omega and prednisolone
Ritz et al
Long term > 3 months
(180 days)
1 of 21 effusive fIFN omega and prednisolone
Ritz et al / Hartmann & Ritz
Remission 264 days 1 of 1 effusive Cyclosporin A, IFN alpha, erythropoietin
Tanaka et al
Remission 14 months 1 of 3 non-effusive PPI Legendre et al 2009
Remission? over 2 years 2 of 3 non-effusive PPI Legendre et al 2009
Survival <100 days
>100 days
>200 days
>300 days
>900 days
1,829 days
29/60
16/60
8
4
2
1
non-effusive FIP presumed
PPI Legendre et al 2017
Very short term
< 7 days 8 of 16 effusive prednisolone only Ritz et al
Short term 7-21 days 4 of16 effusive prednisolone only Ritz et al
Medium term 21 days to 3 months
4 of 16 effusive prednisolone only Ritz et al
Long term > 3 months 0 of 16 effusive prednisolone only Ritz et al
Addie: Feline infectious peritonitis treatment
www.catvirus.com
15
Survived 65 days 2 of 3 effusive anti-TNF-alpha MAb Doki et al
Remission 12 months 1 of 1 non-effusive FIP suspected
Darbepoietin, immunosuppressants and kidney transplant
Chalhoub et al
Prolonged survival
787 days 1 of 1 effusive / MLN FIP confirmed
meloxicam, metronidazole, cefovecin, amoxicillin-clavulanic acid, tramadol hydrochloride
Hugo and Reading 2015
IFN = interferon PPI = polyprenyl immunostimulant
FURTHER INFORMATION WEBSITES FIP website by D. Addie: www.catvirus.com. You will find more extensive notes there, plus the FIP
prognosis excel file.
YouTube channel: www.youtube.com/user/DrDianeDAddie
Webinarvet previous FIP webinars: www.thewebinarvet.com/speaker/diane-addie
University of Glasgow Veterinary Diagnostic Laboratory: www.gla.ac.uk/schools/vet/cad/
The book for cat guardians, veterinary nurses and students, FIP and Coronavirus by Diane D. Addie, is
available from Amazon.
To contact me: email [email protected]. Please consider becoming a veterinary subscriber to
catvirus.com to be kept informed of my latest research.
ACKNOWLEDGEMENTS I am eternally grateful to the guardians of cats with FIP and with FCoV infection: these grief-stricken
souls have been beyond generous in allowing me to use their stories and photographs and many have
gone on to financially support my work. I also profoundly thank the veterinary surgeons of these cats,
who have gone beyond the call of duty in sharing information. My work wzxould not have been
possible without these people, since I refused to use laboratory cats for my research. I sincerely thank
donors to my research, and the catvirus.com subscribers who support me personally.
I thank the staff of the Veterinary Diagnostic Laboratory Laboratory (VDS) of the University of
Glasgow, without whom my work would not be possible. I am grateful to scientific and veterinary
colleagues worldwide and in the European Advisory Board of Cat Disease for useful discussions and
advice. Last but not least, many thanks to Anthony Chadwick and the staff of Webinarvet for allowing
me such an extensive series on FIP.
DECLARATION OF LACK OF VESTED INTERESTS Apart from a fee from Webinarvet and occasional locum employment at VDS, I have no vested interests
in any of the products mentioned in this webinar: I hold no shares or directorships of any companies and
Addie: Feline infectious peritonitis treatment
www.catvirus.com
16
no other kind of benefit will come to me as a result of mentioning any specific products: I am
completely independent.
REFERENCES Acar DD, Olyslaegers DAJ, Dedeurwaerder A, Roukaerts IDM, Baetens W, Van Bockstael S, De Gryse GMA, Desmarets
LMB, Nauwynck HJ: Upregulation of endothelial cell adhesion molecules characterizes veins close to granulomatous
infiltrates in the renal cortex of cats with feline infectious peritonitis and is indirectly triggered by feline infectious
peritonitis virus-infected monocytes in vitro. Journal of General Virology 2016, 97:2633-2642.
Addie, D.D., and Jarrett, J.O. 2001. Use of a reverse-transcriptase polymerase chain reaction for monitoring feline
coronavirus shedding by healthy cats. Vet. Rec. 148:649-653.
Addie D.D, Schaap I.A.T, Nicolson L, Jarrett O. 2003 Persistence and transmission of natural type I feline coronavirus
infection. J. Gen. Virol. 84 (Pt 10), 2735-2744.
Addie DD. Ishida T. 2008 Feline infectious peritonitis – therapy and prevention. Kirk’s Current Veterinary Therapy XIV
Edited by: John D. Bonagura, DVM, MS, DACVIM, David C. Twedt, DVM, DACVIM. Saunders, Elsevier.1295 – 1299.
Addie D, Belak S, Boucrat-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, Hartmann K, Hosie MJ, Marsilio F, Lloret
A, Lutz H, Pennisi MG, Radford AD, Thiry E, Truyen U, Horzinek MC. 2009 Feline infectious peritonitis. ABCD
guidelines on prevention and management. JFMS. 11 7 594-604.
Addie DD, le Poder S, Burr P, Decaro N, Graham E, Hofmann-Lehmann R, Jarrett O, McDonald M, Meli ML. 2015 Utility
of feline coronavirus antibody tests J Feline Med Surg 17(2):152-62.
Allijn IE, Vaessen SF, Quarles van Ufford LC, Beukelman KJ, de Winther MP, Storm G, Schiffelers RM. 2016 Head-to-
Head Comparison of Anti-Inflammatory Performance of Known Natural Products In Vitro. PLoS One. 11(5):e0155325. doi:
10.1371/journal.pone.0155325. eCollection 2016.
Black V, Adamantos S, Barfield D, Tasker S. 2016 Feline non-regenerative immune-mediated anaemia: features and
outcome in 15 cases. J Feline Med Surg. 18(8):597-602.
Brooks BM, Thomas AL, Coleman JW. Benzylpenicillin differentially conjugates to IFN-gamma, TNF-alpha, IL-1beta, IL-4
and IL-13 but selectively reduces IFN-gamma activity. Clin Exp Immunol. 2003 Feb;131(2):268-74.
Chalhoub S., Langston C.E., Farrelly J. 2012 The Use of Darbepoetin to Stimulate Erythropoiesis in Anemia of Chronic
Kidney Disease in Cats: 25 Cases J Vet Intern Med 26:363–369.
Corna G, Campana L, Pignatti E, Castiglioni A, Tagliafico E, Bosurgi L, Campanella A, Brunelli S, Manfredi AA, Apostoli
P, Silvestri L, Camaschella C, Rovere-Querini P. 2010 Polarization dictates iron handling by inflammatory and alternatively
activated macrophages. Haematologica. 95(11):1814-22.
Colpaert S, Liu Z, De Greef B, Rutgeerts P, Ceuppens JL, Geboes K. Effects of anti-tumour necrosis factor, interleukin-10
and antibiotic therapy in the indometacin-induced bowel inflammation rat model. Aliment Pharmacol Ther. 2001
Nov;15(11):1827-36.
Dean GA, Olivry T, Stanton C, Pedersen NC. 2003 In vivo cytokine response to experimental feline infectious peritonitis
virus infection. Vet Microbiol.97(1-2):1-12.
Dewerchin HL, Cornelissen E, Nauwynck HJ. 2005 Replication of feline coronaviruses in peripheral blood monocytes. Arch
Virol. 150(12):2483-500.
Doki T, Takano T, Nishiyama Y, Nakamura M, Hohdatsu T. 2013 Generation, characterization and therapeutic potential of
anti-feline TNF-alpha MAbs for feline infectious peritonitis. Res Vet Sci. 95(3):1248-54.
Doki T, Takano T, Hohdatsu T. 2016a Development of a mouse-feline chimeric antibody against feline tumor necrosis
factor-alpha. J Vet Med Sci. 78(9):1447-1455.
Addie: Feline infectious peritonitis treatment
www.catvirus.com
17
Doki T, Takano T, Kawagoe K, Kito A, Hohdatsu T. 2016b Therapeutic effect of anti-feline TNF-alpha monoclonal
antibody for feline infectious peritonitis.
Dufour V, Millon L, Faucher JF, Bard E, Robinet E, Piarroux R, Vuitton DA, Meillet D. Effects of a short-course of
amoxicillin/clavulanic acid on systemic and mucosal immunity in healthy adult humans. Int Immunopharmacol. 2005
May;5(5):917-28.
Duthie S., Eckersall P.D., Addie D.D., Lawrence C.E., Jarrett O. 1997 Value of α1-acid glycoprotein in the diagnosis of
feline infectious peritonitis. Veterinary Record 141 12 299-303
Felten S, Weider K, Doenges S, Gruendl S, Matiasek K, Hermanns W, Mueller E, Matiasek L, Fischer A, Weber K,
Hirschberger J, Wess G, Hartmann K. 2017 Detection of feline coronavirus spike gene mutations as a tool to diagnose feline
infectious peritonitis. J Feline Med Surg. 19(4):321-335.
Fiore M, Maraolo AE, Gentile I, Borgia G, Leone S, Sansone P, Passavanti MB, Aurilio C, Pace MC. Current concepts and
future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis. World J Hepatol.
2017 Oct 28;9(30):1166-1175.
Gan ZS, Wang QQ, Li JH, Wang XL, Wang YZ, Du HH. 2017 Iron Reduces M1 Macrophage Polarization in RAW264.7
Macrophages Associated with Inhibition of STAT1. Mediators Inflamm. 2017:8570818.
Giori L, Giordano A, Giudice C, Grieco V, Paltrinieri S. 2011 Performances of different diagnostic tests for feline infectious
peritonitis in challenging clinical cases. J Small Anim Pract. 52(3):152-7.
Goitsuka R., Ohashi T., Ono K., Yasukawa K., Koishibara Y., Fukui H., Ohsugi Y., Hasegawa A. 1990 IL-6 activity in
feline infectious peritonitis. J. Immunol. 144 2599-2603
Gunn-Moore D, McCann T. 2004 Use of recombinant feline interferon to treat feline infectious peritonitis. Veterinary
Interferon Handbook. Ed. Karine de Mari. Virbac 118-124
Guru SR, Kothiwale SV, Saroch N, Guru RC. Comparative evaluation of inhibitory effect of curcumin and doxycycline on
matrix metalloproteinase-9 activity in chronic periodontitis. Indian J Dent Res. 2017 Sep-Oct;28(5):560-565.
Hartmann K, Ritz S. 2008a Feline Infectious Peritonitis: Clinical Case Veterinary Interferon Handbook 2nd
edition. Ed. K.
de Mari. Virbac SA, BP 27, O6510 CARROS, France. 147 - 152
Hartmann K, Ritz S. 2008b Treatment of cats with feline infectious peritonitis. Vet Immunol Immunopathol. May 15;123(1-
2):172-5.
Herrewegh AAPM, Mahler M., Hedrich HJ, Haagmans BL, Egberink HF., Horzinek MC., Rottier PJM, de Groot RJ. 1997
Persistence and evolution of feline coronavirus in a closed cat-breeding colony. Virology 234 349-363
Hugo TB, Heading KL. Prolonged survival of a cat diagnosed with feline infectious peritonitis by immunohistochemistry.
The Canadian Veterinary Journal. 2015;56(1):53-58.
Iida T, Satoh S, Nakagaki S, Shimizu H, Kaneto H. 2016 Autoimmune Hemolytic Anemia Triggered by Infection with
Human Parvovirus B19 after Total Abdominal Colectomy for Ulcerative Colitis. Intern Med. 55(6):677-81.
Ishida T, Shibanai A, Tanaka S, Uchida K, Mochizuki M. 2004 Use of recombinant feline interferon and glucocorticoid in
the treatment of feline infectious peritonitis. J Feline Med Surg. 6(2):107-109.
Karalyan Z, Zakaryan H, Arakelova E, Aivazyan V, Tatoyan M, Kotsinyan A, Izmailyan R, Karalova E. 2016 Evidence of
hemolysis in pigs infected with highly virulent African swine fever virus. Vet World. 9(12):1413-1419.
Kim Y, Liu H, Galasiti Kankanamalage AC, Weerasekara S, Hua DH, Groutas WC, Chang K-O, Pedersen NC. (2016)
Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
PLoS Pathog 12(3): e1005531.
Addie: Feline infectious peritonitis treatment
www.catvirus.com
18
Kim Y, Liu H, Galasiti Kankanamalage AC, Weerasekara S, Hua DH, Groutas WC, Chang K-O, Pedersen NC. (2016)
Correction: Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease
Inhibitor. PLoS Pathog 12(5): e1005650. doi:10.1371/journal.ppat.1005650
Kipar A, May H, Menger S, Weber M, Leukert W, Reinacher M. 2005 Morphologic features and development of
granulomatous vasculitis in feline infectious peritonitis. Vet Pathol. 42(3):321-30.
Kraml P. 2017 The role of iron in the pathogenesis of atherosclerosis. Physiol Res. 2017 Apr 5;66(Supplementum 1):S55-
S67.
Lee M, Isaacs J. 2017 The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive,
systemic-onset juvenile idiopathic arthritis. Eur J Rheumatol. 4(1):68-69.
Legendre AM, Bartges JW. 2009 Effect of Polyprenyl Immunostimulant on the survival times of three cats with the dry form
of feline infectious peritonitis. J Feline Med Surg. 11 624-626.
Legendre AM, Kuritz T, Galyon G, Baylor VM, Heidel RE. 2017 Polyprenyl Immunostimulant Treatment of Cats with
Presumptive Non-Effusive Feline Infectious Peritonitis In a Field Study. Front Vet Sci. 4:7.
Leray V, Freuchet B, Le Bloc'h J, Jeusette I, Torre C, Nguyen P. 2016 Effect of citrus polyphenol- and curcumin-
supplemented diet on inflammatory state in obese cats. Br J Nutr. 106 Suppl 1:S198-201.
Longstaff L, Porter E, Crossley VJ, Hayhow SE, Helps CR, Tasker S. 2017 Feline coronavirus quantitative reverse
transcriptase polymerase chain reaction on effusion samples in cats with and without feline infectious peritonitis J Feline
Med Surg 19(2):240-245.
Lovelace ES, Polyak SJ. 2015 Natural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune
and Inflammatory Function during Chronic Infection. Viruses. 7(12):6218-32.
Mazzone GL, Rigato I, Ostrow JD, Bossi F, Bortoluzzi A, Sukowati CHC, Tedesco F, Tiribelli C: Bilirubin inhibits the
TNFα-related induction of three endothelial adhesion molecules. Biochemical and biophysical research communications
2009, 386:338-344.
Morris JG, Rogers QR. 1978 Arginine: an essential amino acid for the cat. J Nutr. 108(12):1944-53.
Mounce BC, Cesaro T, Carrau L, Vallet T, Vignuzzi M. 2017 Curcumin inhibits Zika and chikungunya virus infection by
inhibiting cell binding. Antiviral Res. 2017 Mar 23. pii: S0166-3542(16)30748-3.
Navarro LA, Wree A, Povero D, Berk MP, Eguchi A, Ghosh S, Papouchado BG, Erzurum SC, Feldstein AE. 2015
Arginase 2 deficiency results in spontaneous steatohepatitis: a novel link between innate immune activation and hepatic de
novo lipogenesis. J Hepatol. 62(2):412-20.
Norris JM, Bosward KL, White JD, Baral RM, Catt MJ, Malik R. 2005 Clinicopathological findings associated with feline
infectious peritonitis in Sydney, Australia: 42 cases (1990 – 2002). Australian Veterinary Journal 83 11 666-673.
Ontanilla Clavijo G, Praena Segovia J, Giráldez Gallego Á, Cordero Matía ME, Sousa Martín JM. 2017 Severe acute
hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus. Rev Esp Enferm
Dig. 2017 Apr 3;109.
Paltrinieri S, Giordano A, Tranquillo V, Guazzetti S. 2007 Critical assessment of the diagnostic value of feline alpha1-acid
glycoprotein for feline infectious peritonitis using the likelihood ratios approach. J Vet Diagn Invest. 19(3):266-72.
Pedersen NC, Sato R, Foley JE, and Poland AM. 2004 Common virus infections in cats, before and after being placed in
shelters, with emphasis on Feline Enteric Coronavirus. JFMS 6 83-88.
Pedersen NC, Kim Y, Liu H, Galasiti Kankanamalage AC, Eckstrand C, Groutas WC, Bannasch M, Meadows JM, Chang
KO. Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis. J Feline Med
Surg. 2017 Sep 1:1098612X17729626.
Addie: Feline infectious peritonitis treatment
www.catvirus.com
19
Pesteanu-Somogyi LD, Radzai C, Pressler BM. 2006. Prevalence of feline infectious peritonitis in specific cat breeds. J
Feline Med Surg 8:1-5.
Porter E, Tasker S, Day MJ, Harley R, Kipar A, Siddell SG, Helps CR. 2014 Amino acid changes in the spike protein
of feline coronavirus correlate with systemic spread of virus from the intestine and not with feline infectious peritonitis. Vet
Res. 45:49.
Pozza ME, Stella JL, Chappuis-Gagnon AC, Wagner SO, Buffington CA. 2008 Pinch-induced behavioral inhibition
('clipnosis') in domestic cats. J Feline Med Surg. 10(1):82-7.
Rath M, Müller I, Kropf P, Closs EI, Munder M. Metabolism via Arginase or Nitric Oxide Synthase: Two Competing
Arginine Pathways in Macrophages. Front Immunol. 2014 Oct 27;5:532.
Riemer F, Kuehner KA, Ritz S, Sauter-Louis C, Hartmann K. 2016 Clinical and laboratory features of cats with feline
infectious peritonitis - a retrospective study of 231 confirmed cases (2000-2010). J Feline Med Surg. 18(4):348-56
Rishi G, Wallace DF, Subramaniam VN. 2015 Hepcidin: regulation of the master iron regulator. Biosci Rep. 35(3) pii:
e00192
Ritz S, Egberink H, Hartmann K. 2007 Effect of feline interferon-omega on the survival time and quality of life of cats with
feline infectious peritonitis. J Vet Intern Med. 21(6):1193-7.
Rohrer C, Suter PF, Lutz H. 1993. The diagnosis of feline infectious peritonitis (FIP): a retrospective and prospective study.
Kleinterpraxis 38 6 379-389.
Satoh R, Kaku A, Satomura M, Kohori M, Noura K, Furukawa T, Kotake M, Takano T, Hohdatsu T. 2011 Development of
monoclonal antibodies (MAbs) to feline interferon (fIFN)-γ as tools to evaluate cellular immune responses to feline
infectious peritonitis virus (FIPV). J Feline Med Surg. 13(6):427-3
Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine
interleukin-6. Biochim Biophys Acta. 2011 May;1813(5):878-88.
Shizuma T (2014) Autoimmune Hemolytic Anemia Following Influenza Virus Infection or Administration of Influenza
Vaccine. J Blood Disorders Transf 5: 200. doi: 10.4172/2155-9864.1000200
Singleton DA, Sánchez-Vizcaíno F, Dawson S, Jones PH, Noble PJM, Pinchbeck GL, Williams NJ, Radford AD. Patterns of
antimicrobial agent prescription in a sentinel population of canine and feline veterinary practices in the United Kingdom. Vet
J. 2017 Jun;224:18-24.
Soller JT, Murua-Escobar H, Willenbrock S, Janssen M, Eberle N, Bullerdiek J, Nolte I. 2007 Comparison of the human and
canine cytokines IL-1(alpha/beta) and TNF-alpha to orthologous other mammalians. J Hered. 98(5):485-90.
Steeil J, Schumacher J, Seibert R, Tobias K. Cefovecin (Convenia) for the treatment of septic peritonitis in a female lion
(Panthera leo). J Zoo Wildl Med. 2012 Sep;43(3):678-81.
Stoddart M.E., Gaskell R.M., Harbour D.A., Gaskell C.J. 1988 Virus shedding and immune responses in cats inoculated with
cell culture-adapted feline infectious peritonitis virus. Veterinary Microbiology. 16 145-158
Swann JW, Szladovits B, Glanemann B: Demographic Characteristics, Survival and Prognostic Factors for Mortality
in Cats with Primary Immune‐ Mediated Hemolytic Anemia. Journal of Veterinary Internal Medicine 2016, 30:147-156.
Takano T, Hohdatsu T, Toda A, Tanabe M, Koyama H. 2007a TNF-alpha, produced by feline infectious peritonitis virus
(FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline
macrophages. Virology. 364(1):64-72
Takano T, Hohdatsu T, Hashida Y, Kaneko Y, Tanabe M, Koyama H. 2007b A "possible" involvement of TNF-alpha in
apoptosis induction in peripheral blood lymphocytes of cats with feline infectious peritonitis. Vet Microbiol. 119(2-4):121-
31
Addie: Feline infectious peritonitis treatment
www.catvirus.com
20
Takano T, Azuma N, Satoh M, Toda A, Hashida Y, Satoh R, Hohdatsu T. 2009 Neutrophil survival factors (TNF-alpha,
GM-CSF, and G-CSF) produced by macrophages in cats infected with feline infectious peritonitis virus contribute to the
pathogenesis of granulomatous lesions. Arch Virol. 154(5):775-81.
Tanaka Y, Sato Y, Osawa S, Inoue M, Tanaka S, Sasaki T. 2012 Suppression of feline coronavirus replication in vitro by
cyclosporin A. Vet Res. 43(1):41
Tanaka Y, Sato Y, Takahashi D, Matsumoto H, Sasaki T: Treatment of a case of feline infectious peritonitis with cyclosporin
A. Veterinary Record Case Reports 2015, 3:e000134
Tasker S, Peters IR, Papasouliotis K, Cue SM, Willi B, Hofmann-Lehmann R, Gruffydd-Jones TJ, Knowles TG, Day MJ,
Helps CR: Description of outcomes of experimental infection with feline haemoplasmas: copy numbers, haematology,
Coombs’ testing and blood glucose concentrations. Veterinary microbiology 2009, 139:323-332.
Teymouri M, Pirro M, Johnston TP, Sahebkar A. 2016 Curcumin as a multifaceted compound against human papilloma virus
infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. Biofactors. 2016 Nov 29.
doi: 10.1002/biof.1344.
Trepanier L. 2015 Glucocorticoids. Clinicians brief. 43-47
Tsai HY, Chueh LL, Lin CN, Su BL. 2011 Clinicopathological findings and disease staging of feline infectious peritonitis:
51 cases from 2003 to 2009 in Taiwan. J Feline Med Surg. 13(2):74-80.
Viviano KR1, Webb JL. 2011 Clinical use of cyclosporine as an adjunctive therapy in the management of feline idiopathic
pure red cell aplasia. J Feline Med Surg. 2011 Dec;13(12):885-95
von Rhein C, Weidner T, Henß L, Martin J, Weber C, Sliva K, Schnierle BS. 2016 Curcumin and Boswellia serrata gum
resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro. Antiviral Res. 125:51-7.
Waner T, Harrus S. Anemia of inflammatory disease. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary
Hematology. 5th ed. Philadelphia: Williams & Wilkins; 2000:205-208.
Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front
Immunol. 2014 Nov 28;5:614.
Weiss DJ, Krehbiel JD, Lund JE. Studies of the pathogenesis of anemia of inflammation: mechanism of impaired
erythropoiesis. Am J Vet Res 1982;44(10):1832-1835.
Weiss DJ 2008 Bone marrow pathology in dogs and cats with non-regenerative immune-mediated haemolytic anaemia and
pure red cell aplasia. J Comp Pathol. 138(1):46-53.
White C, Reine N. 2009 Feline Nonregenerative Anemia: Pathophysiology and Etiologies. Compendium 31 7
Worthing KA, Wigney DI, Dhand NK, Fawcett A, McDonagh P, Malik R, Norris JM. 2012 Risk factors for feline infectious
peritonitis in Australian cats. J Feline Med Surg. 14(6):405-12.
Xing Y, Liqi Z, Jian L, Qinghua Y, Qian Y. Doxycycline Induces Mitophagy and Suppresses Production of Interferon-β in
IPEC-J2 Cells. Front Cell Infect Microbiol. 2017 Feb 1;7:21.
Zhu L, Ding X, Zhang D, Yuan Ch, Wang J, Ndegwa E, Zhu G. 2015 Curcumin inhibits bovine herpesvirus type 1 entry into
MDBK cells. Acta Virol. 59(3):221-7.
Top Related